Galectin-9 ameliorates herpes simplex virus-induced inflammation through apoptosis

Immunobiology

Volumn 217, Issue 6, 2012, Pages 657-666

  Shim, Ju A ^a   Park, Sun ^a   Lee, Eun So ^a   Niki, Toshiro ^b   Hirashima, Mitsuomi ^b   Sohn, Seonghyang ^a  

^a Ajou University   (South Korea)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Behcet's disease; Galectin 9; HSV; Inflammation; Tim 3

Indexed keywords

ECALECTIN; REGULATOR PROTEIN; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; HERPES SIMPLEX VIRUS; LIGAND BINDING; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TREATMENT DURATION; UPREGULATION;

ANIMALS; APOPTOSIS; BEHCET SYNDROME; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GALECTINS; GENE EXPRESSION; HERPES SIMPLEX; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; MACROPHAGES; MALE; MICE; MICE, INBRED ICR; RECEPTORS, VIRUS; SIMPLEXVIRUS;

EID: 84860245718     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.11.002     Document Type: Article

References (62)

1. Alter G., Malenfant J.m., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 2004, 294:15-22.
2. Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., Chandwaskar R., Karman J., Su E.W., Hirashima M., Bruce J.N., Kane L.P., Kuchroo V.K., Hafler D.A. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007, 318:1141-1143.
3. Arikawa T., Saita N., Oomizu S., Ueno M., Matsukawa A., Katoh S., Kojima K., Nagahara K., Miyake M., Yamauchi A., Kohrogi H., Hirashima M. Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Eur. J. Immunol. 2010, 40:548-558.
4. Bang D., Yoon K.H., Chung H.G., Choi E.H., Lee E.S., Lee S. Epidemiological and clinical features of Behcet's disease in Korea. Yonsei Med. J. 1997, 38:428-436.
5. Behcet H. Ueber rezidivierende, aphthoese durch ein virus verursachte geschwuere am mund, am auge und an den genitalien. Dermatol. Wochenschr. 1937, 105:1152-1157.
6. Chang M.H., Karageorgos L.E., Meikle P.J. CD107a (LAMP-1) and CD107b (LAMP-2). J. Biol. Regul. Homeost. Agents 2002, 16:147-151.
7. Choi B., Hwang Y., Kwon H.J., Lee E.S., Park K.S., Bang D., Lee S., Sohn S. Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model. J. Dermatol. Sci. 2008, 52:87-97.
8. Chou F.C., Shieh S.J., Sytwu H.K. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur. J. Immunol. 2009, 39:2403-2411.
9. Chun H.Y., Chung J.W., Kim H.A., Yun J.M., Jeon J.Y., Ye Y.M., Kim S.H., Park H.S., Suh C.H. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J. Clin. Immunol. 2007, 27:461-466.
10. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
11. da Silva C.L., Gonçalves R., dos Santos F., Andrade P.Z., Almeida-Porada G., Cabral J.M. Dynamic cell-cell interactions between cord blood hematopoietic progenitors and the cellular niche are essential for the expansion of CD34(+), CD34(+)CD38(-) and early lymphoid CD7(+) cells. J. Tissue Eng. Regen. Med. 2010, 4:149-158.
12. Dai S.Y., Nakagawa R., Itoh A., Murakami H., Kashio Y., Abe H., Katoh S., Kontani K., Kihara M., Zhang S.L., Hata T., Nakamura T., Yamauchi A., Hirashima M. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J. Immunol. 2005, 175:2974-2981.
13. Direskeneli H., Ergun T., Yavuz S., Hamuryudan V., Eksioglu-Demiralp E. Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease. Clin. Rheumatol. 2008, 27:373-375.
14. Dutton R.W., Bradley L.M., Swain S.L. T cell memory. Annu. Rev. Immunol. 1998, 16:201-223.
15. Edwards C.K. Drug discovery and development for inflammatory diseases. Expert Opin. Ther. Targets 2004, 8:151-163.
16. Esin Aktas, Umut Can Kucuksezer, Sema Bilgic, Gaye Erten, Gunnur Deniz Relationship between CD107a expression and cytotoxic activity. Cell. Immunol. 2009, 254:149-154.
17. Frassanito M.A., Dammacco R., Cafforio P., Dammacco F. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 1999, 42:1967-1974.
18. Hastings W.D., Anderson D.E., Kassam N., Koguchi K., Greenfield E.A., Kent S.C., Zheng X.X., Strom T.B., Hafler D.A., Kuchroo V.K. Tim-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur. J. Immunol. 2009, 39:2492-2501.
19. Hirohata S., Suda H., Hashimoto T. Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease. J. Neurol. Sci. 1998, 159:181-185.
20. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G.G., Chou Y.K., Bourdette D., Ziegler S.F., Offner H., Vandenbark A.A. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 2005, 81:45-52.
21. Ilhan F., Demir T., Türkçüoĝlu P., Turgut B., Demir N., Gödekmerdan A. Th1 polarization of the immune response in uveitis in Behçet's disease. Can. J. Ophthalmol. 2008, 43:105-108.
22. Katoh S., Ishii N., Nobumoto A., Takeshita K., Dai S.Y., Shinonaga R., Niki T., Nishi N., Tominaga A., Yamauchi A., Hirashima M. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am. J. Respir. Crit. Care Med. 2007, 176:27-35.
23. Kim H.J., Bang D., Lee S.H., Yang D.S., Kim D.H., Lee K.H., Lee S., Kim H.B., Hong W.P. Behcet's syndrome in Korea: a look at the clinical picture. Yonsei Med. J. 1988, 29:72-78.
24. Koenig J.M., Baron S., Luo D., Benson N.A., Deisseroth A.B. L-selectin expression enhances clonogenesis of CD34+ cord blood progenitors. Pediatr. Res. 1999, 45:867-870.
25. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
26. Lee E.S., Lee S., Bang D., Sohn S. Detection of herpes simplex virus DNA by polymerase chain reaction in genital ulcer of patients with Behcet's disease. Rev. Rhum. 1996, 63:532.
27. Lee E.S., Lee S., Bang D., Sohn S., Park C., Lee K. Herpes simplex virus detection by polymerase chain reaction in intestinal ulcer of patients with Behcet's disease. J. Invest. Dermatol. 1993, 101:474.
28. Lee H.Y., Hong Y.K., Yun H.J., Kim Y.M., Kim J.R., Yoo W.H. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 2008, 47:789-794.
29. Lee S., Bang D., Cho Y.H., Lee E.S., Sohn S. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease. Arch. Dermatol. Res. 1996, 288:179-183.
30. Li X., Chen G., Li Y., Wang R., Wang L., Lin Z., Gao X., Feng J., Ma Y., Shen B., Li Y., Han G. Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease. Clin. Immunol. 2010, 134:169-177.
31. Liu Y., Shu Q., Gao L., Hou N., Zhao D., Liu X., Zhang X., Xu L., Yue X., Zhu F., Guo C., Liang X., Ma C. Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin. Immunol. 2010, 137:288-295.
32. Lord S.J., Rajotte R.V., Korbutt G.S., Bleackley R.C. Granzyme B: a natural born killer. Immunol. Rev. 2003, 193:31-38.
33. Meyers J.H., Sabatos C.A., Chakravarti S., Kuchroo V.K. The Tim gene family regulates autoimmune and allergic diseases. Trends Mol. Med. 2005, 11:362-369.
34. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., Koup R.A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003, 281:65-78.
35. Middleton J., Americh L., Gayon R., Julien D., Mansat M., Mansat P., Anract P., Cantagrel A., Cattan P., Reimund J.M., Aguilar L., Amalric F., Girard J.P. A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J. Pathol. 2005, 206:260-268.
36. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., Manning S., Greenfield E.A., Coyle A.J., Sobel R.A., Freeman G.J., Kuchroo V.K. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002, 415:536-541.
37. Mudter J., Neurath M.F. IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm. Bowel Dis. 2007, 13:1016-1023.
38. Nagahara K., Arikawa T., Oomizu S., Kontani K., Nobumoto A., Tateno H., Watanabe K., Niki T., Katoh S., Miyake M., Nagahata S., Hirabayashi J., Kuchroo V.K., Yamauchi A., Hirashima M. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J. Immunol. 2008, 181:7660-7669.
39. Nakae S., Iikura M., Suto H., Akiba H., Umetsu D.T., Dekruyff R.H., Saito H., Galli S.J. Tim-1 and Tim-3 enhancement of Th2 cytokine production by mast cells. Blood 2007, 110:2565-2568.
40. Nishimoto N., Kishimoto T. Humanized antihuman IL-6 receptor antibody, tocilizumab. Handb. Exp. Pharmacol. 2008, 181:151-160.
41. Niwa H., Satoh T., Matsushima Y., Hosoya K., Saeki K., Niki T., Hirashima M., Yokozeki H. Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation. Clin. Immunol. 2009, 132:184-194.
42. O'Keeffe M., Hochrein H., Vremec D., Scott B., Hertzog P., Tatarczuch L., Shortman K. Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors. Blood 2003, 101:1453-1459.
43. Pay S., Simsek I., Erdem H., Pekel A., Musabak U., Sengul A., Dinc A. Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization?. Clin. Exp. Rheumatol. 2007, 25:34-40.
44. Ricciardelli I., Lindley K.J., Londei M., Quaratino S. Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. Immunology 2008, 125:178-183.
45. Rissoan M.C., Duhen T., Bridon J.M., Bendriss-Vermare N., Péronne C., de Saint Vis B., Brière F., Bates E.E. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 2002, 100:3295-3303.
46. Saito S., Murakoshi K., Kotake S., Kamatani N., Tomatsu T. Granzyme B induces apoptosis of chondrocytes with natural killer cell-like cytotoxicity in rheumatoid arthritis. J. Rheumatol. 2008, 35:1932-1943.
47. Sánchez-Fueyo A., Tian J., Picarella D., Domenig C., Zheng X.X., Sabatos C.A., Manlongat N., Bender O., Kamradt T., Kuchroo V.K., Gutiérrez-Ramos J.C., Coyle A.J., Strom T.B. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 2003, 4:1093-1101.
48. Satterthwaite A.B., Burn T.C., Le Beau M.M., Tenen D.G. Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics 1992, 12:788-794.
49. Seki M., Oomizu S., Sakata K.M., Sakata A., Arikawa T., Watanabe K., Ito K., Takeshita K., Niki T., Saita N., Nishi N., Yamauchi A., Katoh S., Matsukawa A., Kuchroo V., Hirashima M. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 2008, 127:78-88.
50. Seki M., Sakata K.M., Oomizu S., Arikawa T., Sakata A., Ueno M., Nobumoto A., Niki T., Saita N., Ito K., Dai S.Y., Katoh S., Nishi N., Tsukano M., Ishikawa K., Yamauchi A., Kuchroo V., Hirashima M. Beneficial effect of galectin-9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum. 2007, 56:3968-3976.
51. Shim J., Byun H.O., Lee Y.D., Lee E.S., Sohn S. Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet's disease-like mouse model. Gene Ther. 2009, 16:415-425.
52. Shim J., Lee E.S., Park S., Bang D., Sohn S. CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model. Cytotherapy 2011, 13:835-847.
53. Shimizu T. Behcet disease (Behcet syndrome). Semin. Arthritis Rheum. 1979, 8:223-260.
54. Sohn S., Lee E.S., Bang D., Lee S. Behçet's disease-like symptoms induced by the herpes simplex virus in ICR mice. Eur. J. Dermatol. 1998, 8:21-23.
55. Sohn S., Lee E.S., Kwon H.J., Lee S.I., Bang D., Lee S. Expression of Th2 cytokines decreases the development of and improves Behçet's disease-like symptoms induced by herpes simplex virus in mice. J. Infect. Dis. 2001, 183:1180-1186.
56. Sziksz E., Kozma G.T., Pállinger E., Komlósi Z.I., Adori C., Kovács L., Szebeni B., Rusai K., Losonczy G., Szabó A., Vannay A. Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. Int. Arch. Allergy Immunol. 2010, 151:308-317.
57. Takahashi T., Kuniyasu Y., Toda M., Sakaguchi N., Itoh M., Iwata M., Shimizu J., Sakaguchi S. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 1998, 10:1969-1980.
58. Trapani J.A., Sutton V.R. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr. Opin. Immunol. 2003, 15:533-543.
59. Wang F., He W., Zhou H., Yuan J., Wu K., Xu L., Chen Z.K. The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft. Cell. Immunol. 2007, 250:68-74.
60. Yalçin B., Arda N., Tezel G.G., Erman M., Alli N. Expressions of vascular endothelial growth factor and CD34 in oral aphthous lesions of Behçet's disease. Anal. Quant. Cytol. Histol. 2006, 28:303-306.
61. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., Kleinschek M.A., Owyang A., Mattson J., Blumenschein W., Murphy E., Sathe M., Cua D.J., Kastelein R.A., Rennick D. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 2006, 116:1310-1316.
62. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., Zheng X.X., Strom T.B., Kuchroo V.K. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 2005, 6:1245-1252.